瑞迪實驗室有限公司(Dr. Reddy's Laboratories Ltd.)從事藥物產品的製造與銷售。該公司總部設於特倫甘納邦的海得拉巴,目前聘有26,944名全職員工。其產品與服務遍及原料藥(APIs)、通用名藥(generics)、品牌通用藥、生物相似藥以及非處方藥(OTC)等核心業務領域。公司主要研究領域包括胃腸道、心血管、糖尿病、腫瘤、疼痛管理和皮膚科。其業務部門主要包括全球通用藥(Global Generics)、藥品服務與原料藥(Pharmaceutical Services and Active Ingredients, PSAI)及其他部門。全球通用藥部門包括公司製造及銷售處方藥與非處方藥成品藥物的業務,這些藥物可供患者直接使用,以品牌名稱(品牌製劑)或與品牌製劑具有療效等效性的通用名成品劑型(通用藥)進行銷售。藥品服務與原料藥部門則包括公司製造及銷售原料藥與中間體的業務。
What is the price performance of Dr. Reddy's Laboratories Ltd stock?
The current price of Dr. Reddy's Laboratories Ltd is $12.28, it has 下降 1.12% in the last trading day.
What are the primary business themes or industries for Dr Reddy's Laboratories Ltd?
Dr Reddy's Laboratories Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Dr Reddy's Laboratories Ltd market cap?
Dr Reddy's Laboratories Ltd's current market cap is $10.2B
Is Dr Reddy's Laboratories Ltd a buy, sell, or hold?
According to wall street analysts, 39 analysts have made analyst ratings for Dr Reddy's Laboratories Ltd, including 8 strong buy, 11 buy, 12 hold, 8 sell, and 8 strong sell